217 related articles for article (PubMed ID: 27978990)
1. Perspectives in regulatory science: translational and clinical pharmacology.
Grillo JA; Huang SM
Drug Discov Today Technol; 2016; 21-22():67-73. PubMed ID: 27978990
[TBL] [Abstract][Full Text] [Related]
2. Clinical pharmacology and the catalysis of regulatory science: opportunities for the advancement of drug development and evaluation.
Zineh I; Woodcock J
Clin Pharmacol Ther; 2013 Jun; 93(6):515-25. PubMed ID: 23571772
[TBL] [Abstract][Full Text] [Related]
3. Best practice in the use of physiologically based pharmacokinetic modeling and simulation to address clinical pharmacology regulatory questions.
Zhao P; Rowland M; Huang SM
Clin Pharmacol Ther; 2012 Jul; 92(1):17-20. PubMed ID: 22713733
[TBL] [Abstract][Full Text] [Related]
4. Office of clinical pharmacology science day: a forum to stimulate innovation in clinical pharmacology.
Owen RP; Jain L; Zhang L; Zineh I
Clin Pharmacol Ther; 2013 Jun; 93(6):471-3. PubMed ID: 23689212
[TBL] [Abstract][Full Text] [Related]
5. The utility of modeling and simulation in drug development and regulatory review.
Huang SM; Abernethy DR; Wang Y; Zhao P; Zineh I
J Pharm Sci; 2013 Sep; 102(9):2912-23. PubMed ID: 23712632
[TBL] [Abstract][Full Text] [Related]
6. ASCPT Task Force for advancing pharmacometrics and integration into drug development.
Goldberger MJ; Singh N; Allerheiligen S; Gobburu JV; Lalonde R; Smith B; Ryder S; Yozviak A
Clin Pharmacol Ther; 2010 Aug; 88(2):158-61. PubMed ID: 20648032
[TBL] [Abstract][Full Text] [Related]
7. The FDA's critical path initiative: a brief introduction.
Coons SJ
Clin Ther; 2009 Nov; 31(11):2572-3. PubMed ID: 20110002
[No Abstract] [Full Text] [Related]
8. Quantitative Systems Pharmacology: A Regulatory Perspective on Translation.
Zineh I
CPT Pharmacometrics Syst Pharmacol; 2019 Jun; 8(6):336-339. PubMed ID: 30924594
[No Abstract] [Full Text] [Related]
9. Clinical pharmacology as a cornerstone of orphan drug development.
Bashaw ED; Huang SM; Coté TR; Pariser AR; Garnett CE; Burckart G; Zhang L; Men AY; Le CD; Charlab R; Gobburu JV; Lesko LJ
Nat Rev Drug Discov; 2011 Oct; 10(11):795-6. PubMed ID: 22037026
[TBL] [Abstract][Full Text] [Related]
10. Industrialization of Quantitative Systems Pharmacology.
Topp B; Trujillo ME; Sinha V
CPT Pharmacometrics Syst Pharmacol; 2019 Jun; 8(6):356-358. PubMed ID: 31087476
[No Abstract] [Full Text] [Related]
11. Catalyzing the Critical Path Initiative: FDA's progress in drug development activities.
Parekh A; Buckman-Garner S; McCune S; ONeill R; Geanacopoulos M; Amur S; Clingman C; Barratt R; Rocca M; Hills I; Woodcock J
Clin Pharmacol Ther; 2015 Mar; 97(3):221-33. PubMed ID: 25670629
[TBL] [Abstract][Full Text] [Related]
12. Regulatory Science - An Underappreciated Component of Translational Research.
Rouse R; Zineh I; Strauss DG
Trends Pharmacol Sci; 2018 Mar; 39(3):225-229. PubMed ID: 29329784
[TBL] [Abstract][Full Text] [Related]
13. Physiologically Based Pharmacokinetic Modeling in Regulatory Science: An Update From the U.S. Food and Drug Administration's Office of Clinical Pharmacology.
Grimstein M; Yang Y; Zhang X; Grillo J; Huang SM; Zineh I; Wang Y
J Pharm Sci; 2019 Jan; 108(1):21-25. PubMed ID: 30385284
[TBL] [Abstract][Full Text] [Related]
14. Regulatory science as a bridge between science and society.
Tominaga T; Asahina Y; Uyama Y; Kondo T
Clin Pharmacol Ther; 2011 Jul; 90(1):29-31. PubMed ID: 21691273
[TBL] [Abstract][Full Text] [Related]
15. Drug development and the FDA's Critical Path Initiative.
Woosley RL; Cossman J
Clin Pharmacol Ther; 2007 Jan; 81(1):129-33. PubMed ID: 17186012
[TBL] [Abstract][Full Text] [Related]
16. Clinical translational science 2020: disruptive innovation redefines the discovery-application enterprise.
Waldman SA; Terzic A
Clin Transl Sci; 2011 Feb; 4(1):69-71. PubMed ID: 21348959
[No Abstract] [Full Text] [Related]
17. The regulatory role of the United States Food and Drug Administration.
Ortiz EM
J Reprod Med; 1972 Apr; 8(4):205-6. PubMed ID: 5029971
[No Abstract] [Full Text] [Related]
18. Advancing regulatory science to bring novel medical devices for use in emergency care to market: the role of the Food and Drug Administration.
Scully CG; Forrest S; Galeotti L; Schwartz SB; Strauss DG
Ann Emerg Med; 2015 Apr; 65(4):400-3. PubMed ID: 25128009
[TBL] [Abstract][Full Text] [Related]
19. Regulatory watch: From big data to smart data: FDA's INFORMED initiative.
Khozin S; Kim G; Pazdur R
Nat Rev Drug Discov; 2017 May; 16(5):306. PubMed ID: 28232724
[No Abstract] [Full Text] [Related]
20. Surviving in the Valley of Death: Opportunities and Challenges in Translating Academic Drug Discoveries.
Parrish MC; Tan YJ; Grimes KV; Mochly-Rosen D
Annu Rev Pharmacol Toxicol; 2019 Jan; 59():405-421. PubMed ID: 30208282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
